How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

570 results for

Interview Questions for the Physician Candidate

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

81. Erectile Dysfunction

The quality of case- control studies and comparative observational studies was rated using the Newcastle-Ottawa Quality Assessment Scale. 1004 Because there is no widely- agreed upon quality assessment tool for single cohort observational studies, the quality of these studies was not assessed. The categorization of evidence strength is conceptually distinct from the quality of individual studies. Evidence strength refers to the body of evidence available for a particular question and includes not only (...) selection. 12,13 The patient’s commitment includes the willingness to absorb information, ask questions, and clearly express his and his partner’s preferences and values. This process results in a sharing of information and responsibility, allowing a collaborative decision regarding diagnostic and treatment plans. Because of the complexity of sexuality and the impact of a sexual relationship on a man’s life, the Panel strongly advocates that a man’s partner be invited to participate in this process

2018 American Urological Association

82. Targeted Immunomodulators for the Treatment of Moderate-to-Severe Plaque Psoriasis: Effectiveness and Value

of this report or should be assumed to support any part of this report, which is solely the work of the ICER team and its affiliated researchers. For a complete list of stakeholders from whom we requested input, please visit: https://icer-review.org/material/psoriasis-stakeholder-list/ Expert Reviewers Alexa B. Kimball, MD Harvard Medical Faculty Physicians Beth Israel Deaconess Medical Center Conflict of Interest Declaration: Alexa B. Kimball is a consultant for Novartis, AbbVie, UCB, Lilly, Janssen (...) and Economic Review, 2018 Page ES4 Evidence Report: Targeted Immunomodulators for Plaque Psoriasis | Condition Update Return to Table of Contents For many of these agents, there is some suggestion of waning effectiveness with continued use, known as biologic fatigue. 21 To maintain effectiveness, physicians often prescribe increasing doses of targeted immunomodulators. On the other hand, physicians occasionally prescribe lower doses of effective medications to decrease out-of-pocket costs. Patients

2018 California Technology Assessment Forum

83. Clinical Consensus Statement: Balloon Dilation of the Sinuses

obstruction, to even obstructive sleep apnea. A recent review of balloon use by physicians within the Department of Defense health care system also indicated that SOD is often used for indications for which there is currently no evidence of efficacy. Furthermore, between 2011 and 2014, the number of balloon SOD procedures increased in excess of the drop in nonballoon procedures. This rise in SOD procedures, without a commensurate reduction in traditional functional endoscopic sinus surgery, has caused (...) increased scrutiny by payers and providers, which is further intensified by concern over potential inappropriate use of the procedure. Given the knowledge gap that exists regarding the role of SOD in managing CRS and the increasing rates of utilization, the Physician Payment Policy Working Group (3P) of the American Academy of Otolaryngology—Head and Neck Surgery (AAO-HNS) submitted SOD to the AAO-HNS Foundation (AAO-HNSF) Guideline Task Force as a potential topic for a clinical practice guideline. Due

2018 American Academy of Otolaryngology - Head and Neck Surgery

84. Targeted Immunomodulators for the Treatment of Moderate-to-Severe Plaque Psoriasis: Effectiveness and Value

contents of this report or should be assumed to support any part of this report, which is solely the work of the ICER team and its affiliated researchers. For a complete list of stakeholders from whom we requested input, please visit: https://icer-review.org/material/psoriasis-stakeholder-list/ Expert Reviewers Alexa B. Kimball, MD Harvard Medical Faculty Physicians Beth Israel Deaconess Medical Center Conflict of Interest Declaration: Alexa B. Kimball is a consultant for Novartis, AbbVie, UCB, Lilly (...) Institute for Clinical and Economic Review, 2018 Page ES4 Final Evidence Report: Plaque Psoriasis Condition Update Return to Table of Contents For many of these agents, there is some suggestion of waning effectiveness with continued use, known as biologic fatigue. 21 To maintain effectiveness, physicians often prescribe increasing doses of targeted immunomodulators. On the other hand, physicians occasionally prescribe lower doses of effective medications to decrease out-of-pocket costs. Patients

2018 California Technology Assessment Forum

85. Sodium and Potassium Intake: Effects on Chronic Disease Outcomes and Risks

Prepared by: RAND Southern California Evidence-based Practice Center Santa Monica, CA Investigators: Sydne J. Newberry, Ph.D. Mei Chung, M.P.H., Ph.D. Cheryl A.M. Anderson, Ph.D., M.P.H., M.S. Christine Chen, M.D., M.P.H., Ph.D. candidate Zhuxuan Fu, M.P.H. Alice Tang, Ph.D., Sc.M. Naisi Zhao, M.H.S., Dr.Ph candidate Marika Booth, M.S. Joyce Marks, B.S. Simon Hollands, M.S., Ph.D. candidate Aneesa Motala, B.A. Jody Larkin, M.S. Roberta Shanman, M.L.S. Susanne Hempel, Ph.D. AHRQ Publication No. 18 (...) , and the health care system as a whole. Transparency and stakeholder input are essential to the Effective Health Care Program. Please visit the Web site (www.effectivehealthcare.ahrq.gov) to see draft research questions and reports or to join an email list to learn about new program products and opportunities for input. We welcome comments on this systematic review. They may be sent by mail to the Task Order Officer named below at: Agency for Healthcare Research and Quality, 5600 Fishers Lane, Rockville, MD

2018 Effective Health Care Program (AHRQ)

86. CAEP FEI | Human Trafficking Awareness: A Learning Module

are trained to recognize child abuse and intimate partner violence, there is no routine education regarding identifying trafficking victims. 5 A study in the United States interviewed trafficking victims in shelters where they learned that in addition to not being identified as needing help, the victims reported being hurt and humiliated by physicians during their encounter in the emergency room. 3 Simple training modules, some as short as 20 minutes, have been shown to have a significant impact (...) CAEP FEI | Human Trafficking Awareness: A Learning Module CAEP FEI | Human Trafficking Awareness: A Learning Module - CanadiEM CAEP FEI | Human Trafficking Awareness: A Learning Module In , by Julianna Deutscher September 21, 2018 Jeremy is a second year resident who is about to see a 25 year old female presenting with abdominal pain. During the history he notices the patient is remarkably quiet and that the patient’s male friend is answering all the questions for her. When Jeremy asks the male

2018 CandiEM

87. Management of Pregnancy

. Nutrition 39 c. Screening 40 d. Education 43 B. One-time Interventions 44 a. Screening and Diagnostic Testing 44 b. Imaging 49 c. Preparing for Delivery 50 d. Postpartum Care 51 C. Referral 52 D. Special Considerations 55 a. High Risk for Preeclampsia 55 b. High Risk for Preterm Delivery 56 c. Over 44 Years of Age 57 d. History of Bariatric Surgery 58 Appendix A: Evidence Review Methodology 62 A. Developing the Scope and Key Questions 62 a. Population(s) 62 b. Interventions 62 c. Comparators 64 d (...) . Outcomes 65 B. Conducting the Systematic Review 67 a. General Criteria for Inclusion in Systematic Review 69 b. Key Question Specific Criteria 70 c. Literature Search Strategy 71 C. Convening the Face-to-face Meeting 71 D. Grading Recommendations 72 E. Recommendation Categorization 75 a. Recommendation Categories and Definitions 75 b. Categorizing Recommendations with an Updated Review of the Evidence 76 c. Categorizing Recommendations without an Updated Review of the Evidence 77 F. Drafting

2018 VA/DoD Clinical Practice Guidelines

88. Antiandrogen Therapies for Nonmetastatic Castration-Resistant Prostate Cancer: Effectiveness and Value

with CRPC and how this affects men and their families, the psychological effects of prostate cancer on a man’s sense of self, the substantial side effects of therapies for prostate cancer, and the sense that burdensome therapy has failed when PSA levels begin to rise leading some to question their prior decisions about therapy. In a 2017 survey report from the Cancer Support Community, 49 patients rated the following factors to be among the “most important” considerations when selecting a treatment (...) the budgetary effects of price premiums. The candidate population in the budget impact model that was eligible for treatment with antiandrogens comprised adult males diagnosed with nmCRPC eligible for first-line therapy with antiandrogens. This reflects the labeled indication for apalutamide and enzalutamide, although the trials examined patients with more rapid PSA doubling times. We estimated an annual incident population of approximately 59,000 patients eligible for treatment with either antiandrogen

2018 California Technology Assessment Forum

89. Evaluation and Management of Testosterone Deficiency

supplementation by the authors. Literature searches included Ovid Medline In-Process & Other Non-Indexed Citations, Ovid MEDLINE, Ovid EMBASE, Ovid Cochrane Central Register of Controlled Trials, Ovid Cochrane Database of Systematic Reviews, and Scopus. Controlled vocabulary supplemented with keywords was used to search for studies according to each defined question. This search included articles published between January 1, 1980 – February 6, 2017 and yielded 15,217 references, 546 (enrolling approximately (...) to testicular radiation, HIV/AIDS, chronic narcotic use, male infertility, pituitary dysfunction, and chronic corticosteroid use even in the absence of symptoms or signs associated with testosterone deficiency. (Moderate Recommendation; Evidence Level: Grade B) 5. The use of validated questionnaires is not currently recommended to either define which patients are candidates for testosterone therapy or to monitor symptom response in patients on testosterone therapy. (Conditional Recommendation; Evidence

2018 American Urological Association

90. Routine Assessment and Promotion of Physical Activity in Healthcare Settings: A Scientific Statement From the American Heart Association

the information we aimed to collect for each device. Of the 9, 1 granted an interview. We also interviewed a technology professional from a southeast healthcare system that has incorporated WAMs into its patient portal to understand its approach, as well as a representative from a large data-aggregation organization. From this initial search, we identified 49 candidate WAMs. We included a WAM in our final assessment if its validity had been evaluated, prioritizing independent studies. We also preferred (...) intervention will solve the problem of insufficient PA in the United States. Rather, improving population levels of PA requires comprehensive efforts to maximize the potential benefits of setting-specific interventions under a coordinated multilevel approach. , Different strategies with various levels of effectiveness have been used to incorporate PA promotion into healthcare settings. Brief PA counseling, initiated by the physician or other healthcare provider (HCP), and the “green prescription” (written

Full Text available with Trip Pro

2018 American Heart Association

91. Improving Quality of Life: Substance Use and Aging

use, as we do in this report, is key to developing new and more tailored strategies for reducing the harms of alcohol and drugs on older adults. Since 2005, the series now known as Substance Use in Canada has highlighted alcohol- and drug-related issues that are in need of greater attention. For this seventh edition, we began with two questions: How can we help people age in a healthy way? and How can we ensure they have the supports they need to sustain a good quality of life in their later years (...) ? Getting the answers to those questions begins by having a dialogue about substance use by older Canadians. It is with that in mind that this report calls for greater awareness and understanding of the issue among healthcare providers and caregivers — and facilitates that understanding through an in-depth exploration of the latest evidence on “successful aging,” the prevalence of substance use among older Canadians, the consequences of substance use in this vulnerable population, and other critical

2018 Canadian Centre on Substance Abuse

92. Using Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients

: Qualitative/semi-quantitative screening assays 57 Chapter 4: Quantitative or definitive assays 64 Chapter 5: Adulterant/Specimen Validity testing 71 Chapter 6: Pharmacogenomic considerations 75 Chapter 7: Reporting, interpretation, and communication of laboratory results with physicians 80 Appendix A: Tables Used for PICO(TS) Questions 86 Appendix B: Summary tables of the evidence-based LMPG recommendations and consensus-based expert opinions 89 Appendix C: Search strategy used for MEDLINE database 93 (...) the laboratory tests (screening or definitive) that were com- pared with other clinician tools (e.g., physician interview, medical record review, prescription monitoring programs, screener and opioid assessment for patients with pain). In general, screening tests have adequate clinical sensitivity but may not be highly spe- Using Clinical Laboratory Tests to Monitor Drug Therapy in Pain Management Patients JANNETTO PJ, BRATANOW N, CLARK WA, HAMILL-RUTH RJ, HAMMETT-STABLER CA, HUESTIS MA, KASSED CA, MCMILLIN

2018 American Academy of Pain Medicine

93. Palliative Care in the Global Setting Resource-Stratified Guideline

questions: (1) Who should provide palliative care in the absence of specialized palliative care physicians, and what is the minimum training necessary to meet the palliative care needs of the community (whether by an oncologist or other clinicians/providers)? (2) What is the most effective model of palliative care delivery? (3) When is the best time to involve a palliative care team in cancer care? (4) What is the role of the nurse in palliative care assessment, pain and symptom control, and drug (...) clinicians should make referrals to palliative care services, but earlier referral is preferable. CLINICAL QUESTION 3 (WORKFORCE, KNOWLEDGE, AND SKILLS): Who should provide palliative care in the absence of specialized palliative care physicians? What is the minimum training necessary to meet the palliative care needs of the community (whether by an oncologist or other clinicians/providers)? Introduction: This clinical question recognizes that outside of maximal settings, palliative care specialists

2018 American Society of Clinical Oncology Guidelines

94. 2018 guidelines for the early management of patients with acute ischemic stroke

. 2018;49:e46–e99 You are viewing the most recent version of this article. Previous versions: Abstract Correction This article has two related Corrections: Background and Purpose— The purpose of these guidelines is to provide an up-to-date comprehensive set of recommendations for clinicians caring for adult patients with acute arterial ischemic stroke in a single document. The intended audiences are prehospital care providers, physicians, allied health professionals, and hospital administrators (...) of clinical questions identified in conjunction with the writing group, the results of which were considered by the writing group for incorporation into this guideline. The systematic reviews “Accuracy of Prediction Instruments for Diagnosing Large Vessel Occlusion in Individuals With Suspected Stroke: A Systematic Review for the 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke” and “Effect of Dysphagia Screening Strategies on Clinical Outcomes After Stroke: A Systematic

2018 American Academy of Neurology

95. 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association

are prehospital care providers, physicians, allied health professionals, and hospital administrators. These guidelines supersede the 2013 guidelines and subsequent updates. Methods— Members of the writing group were appointed by the American Heart Association Stroke Council’s Scientific Statements Oversight Committee, representing various areas of medical expertise. Strict adherence to the American Heart Association conflict of interest policy was maintained. Members were not allowed to participate (...) . An independent evidence review committee was commissioned to perform a systematic review of a limited number of clinical questions identified in conjunction with the writing group, the results of which were considered by the writing group for incorporation into this guideline. The systematic reviews “Accuracy of Prediction Instruments for Diagnosing Large Vessel Occlusion in Individuals With Suspected Stroke: A Systematic Review for the 2018 Guidelines for the Early Management of Patients With Acute Ischemic

2018 American Heart Association

96. Screening of fetal aneuploidies whereby non-invasive prenatal test (NIPT)

INVOLVEMENT 27 2.3 SOURCE OF ASSESSMENT ELEMENTS 28 2.4 SEARCH 28 2.5 LITERATURE SELECTION AND DATA EXTRACTION 29 2.6 QUALITY RATING OF STUDIES 31 2.7 STATISTICAL ANALYSIS 31 2.8 DESCRIPTION OF THE EVIDENCE USED 32 2.9 DEVIATIONS FROM PROJECT PLAN 40 3 DESCRIPTION AND TECHNICAL CHARACTERISTICS OF TECHNOLOGY 41 3.1 RESEARCH QUESTIONS 41 3.2 RESULTS 41 3.3 DISCUSSION 56 4 HEALTH PROBLEM AND CURRENT USE OF THE TECHNOLOGY 58 4.1 RESEARCH QUESTIONS 58 4.2 RESULTS 58 4.3 DISCUSSION 63 5 CLINICAL EFFECTIVENESS (...) 65 5.1 RESEARCH QUESTIONS 65 5.2 INCLUDED STUDIES 65 5.2.1 NIPT as a primary screening test for the general singleton pregnancy population (total replacement of FCT) 65 5.2.2 NIPT as an add-on to FCT for the high risk singleton pregnancy population 67 5.2.3 NIPT as an add-on to FCT for the high-and intermediate-risk singleton pregnancy population 69 5.2.4 NIPT as an add-on to FCT for the high risk population twin pregnancy population 70 5.3 TEST ACCURACY 72 5.3.1 NIPT as a primary screening test

2018 EUnetHTA

97. Regorafenib (Stivarga) indicated as monotherapy for the treatment of adult patients with hepatocellular carcinoma (HCC) who have been previously treated with sorafenib treatment

10 INTRODUCTION 10 METHODS 10 RESULTS 11 DISCUSSION 14 CONCLUSION 14 1 SCOPE 15 2 METHODS AND EVIDENCE INCLUDED 16 2.1 ASSESSMENT TEAM 16 2.2 SOURCE OF ASSESSMENT ELEMENTS 16 2.3 SEARCH 16 2.4 STUDY SELECTION 17 2.5 DATA EXTRACTION AND ANALYSES 19 2.6 QUALITY RATING 19 2.7 DESCRIPTION OF THE EVIDENCE USED 20 2.8 DEVIATIONS FROM PROJECT PLAN 20 3 DESCRIPTION AND TECHNICAL CHARACTERISTICS OF TECHNOLOGY (TEC) 21 3.1 RESEARCH QUESTIONS 21 3.2 RESULTS 21 4 HEALTH PROBLEM AND CURRENT USE (...) OF THE TECHNOLOGY (CUR) 24 4.1 RESEARCH QUESTIONS 24 4.2 RESULTS 24 5 CLINICAL EFFECTIVENESS (EFF) 29 5.1 RESEARCH QUESTIONS 29 5.2 RESULTS 29 6 SAFETY (SAF) 43 6.1 RESEARCH QUESTIONS 43 6.2 RESULTS 43 7 POTENTIAL ETHICAL, ORGANISATIONAL, PATIENT AND SOCIAL, AND LEGAL ASPECTS (ETH, ORG, SOC, LEG) 48 8 PATIENT INVOLVEMENT 49 9 DISCUSSION 50 10 CONCLUSION 52 11 REFERENCES 53 APPENDIX 1: METHODS AND DESCRIPTION OF THE EVIDENCE USED 56 DOCUMENTATION OF THE SEARCH STRATEGIES 56 DESCRIPTION OF THE EVIDENCE USED 62

2018 EUnetHTA

98. Alcoholic Liver Disease

AH should preferably be hospitalized for management Treatment of alcoholic hepatitis 11. Severe AH is identi? ed by Maddrey’s discriminant function score >32 or MELD score >20 12. Systemic in? ammatory response syndrome (SIRS) at admission predisposes to acute kidney injury and multi-organ failure, which are associated with a poor prognosis. Physicians should take appropriate measures to prevent renal injury, such as avoidance of nephrotoxic drugs, judicious use of diuretics, and low threshold (...) >0.45 15. Patients non-responsive to corticosteroids, ineligible for early LT, and with multiple organ failures, may be considered for palliative therapy Liver transplantation in alcoholic liver disease Liver transplantation for alcoholic cirrhosis 16. Physicians should consider LT while formulating a management plan for patients with end-stage ALD 17. The decision on LT evaluation should not be based solely on minimum 6 months of alcohol abstinence, and other criteria should be taken into con

2018 American College of Gastroenterology

99. Paediatric Urology

. Ultrasound guidance of suprapubic bladder aspiration in neonates. J Pediatr, 1993. 123: 789. 339. Hildebrand, W.L., et al. Suprapubic bladder aspiration in infants. Am Fam Physician, 1981. 23: 115. 340. Kozer, E., et al. Pain in infants who are younger than 2 months during suprapubic aspiration and transurethral bladder catheterization: a randomized, controlled study. Pediatrics, 2006. 118: e51. 341. Vaillancourt, S., et al. To clean or not to clean: effect on contamination rates in midstream urine (...) . Enhanced urinalysis improves identification of febrile infants ages 60 days and younger at low risk for serious bacterial illness. Pediatrics, 2001. 108: 866. 346. Mayo, S., et al. Clinical laboratory automated urinalysis: comparison among automated microscopy, flow cytometry, two test strips analyzers, and manual microscopic examination of the urine sediments. J Clin Lab Anal, 2008. 22: 262. 347. Kass, E.H. Asymptomatic infections of the urinary tract. Trans Assoc Am Physicians, 1956. 69: 56. 348

2018 European Association of Urology

100. Male Sexual Dysfunction

., et al. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res, 1999. 11: 319. 89. Mulhall, J.P., et al. Validation of the erection hardness score. J Sex Med, 2007. 4: 1626. 90. Whooley, M.A., et al. Case-finding instruments for depression. Two questions are as good as many. J Gen Intern Med, 1997. 12: 439. 91. Khera, M., et al. Diagnosis and Treatment of Testosterone

2018 European Association of Urology

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>